Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Weber

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
Biochemistry|May 31, 2022
<i>Arabidopsis</i> PFA-DSP-Type Phosphohydrolases Target Specific Inositol Pyrophosphate MessengersPhilipp Gaugler, Robin Schneider, Guizhen Liu, et al.
Journal of the American College of Cardiology|May 27, 2026
Photon-Counting Detector CT Reduces Calcium Overestimation Compared With Energy-Integrating Detector CT: Micro-CT Validation in Cadaveric ArteriesDoosup Shin, Lionel Chong, Matthew Cannata, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
Lancet (London, England)|September 21, 2010
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialSheena McCormack, Gita Ramjee, Anatoli Kamali, et al.
Vaccine|May 27, 2008
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C aloneSheena McCormack, Wolfgang Stöhr, Tristan Barber, et al.
Journal of the American College of Cardiology|October 28, 2024
Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery DiseaseKoshiro Sakai, Doosup Shin, Mandeep Singh, et al.
Vaccine|May 27, 2008
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumPierre-Alexandre Bart, Ruth Goodall, Tristan Barber, et al.
Nature Communications|October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruptionJacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
Biochemistry|May 31, 2022
<i>Arabidopsis</i> PFA-DSP-Type Phosphohydrolases Target Specific Inositol Pyrophosphate MessengersPhilipp Gaugler, Robin Schneider, Guizhen Liu, et al.
Journal of the American College of Cardiology|May 27, 2026
Photon-Counting Detector CT Reduces Calcium Overestimation Compared With Energy-Integrating Detector CT: Micro-CT Validation in Cadaveric ArteriesDoosup Shin, Lionel Chong, Matthew Cannata, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
Lancet (London, England)|September 21, 2010
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialSheena McCormack, Gita Ramjee, Anatoli Kamali, et al.
Vaccine|May 27, 2008
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C aloneSheena McCormack, Wolfgang Stöhr, Tristan Barber, et al.
Journal of the American College of Cardiology|October 28, 2024
Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery DiseaseKoshiro Sakai, Doosup Shin, Mandeep Singh, et al.
Vaccine|May 27, 2008
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumPierre-Alexandre Bart, Ruth Goodall, Tristan Barber, et al.
Nature Communications|October 10, 2015
Immunological biomarkers predict HIV-1 viral rebound after treatment interruptionJacob Hurst, Matthias Hoffmann, Matthew Pace, et al.
Pageof 12